menu
    • menu
    [{"orgOrder":0,"company":"Avanzanite Bioscience","sponsor":"SIFI","pharmaFlowCategory":"D","therapeuticArea":"Ophthalmology","country":"NETHERLANDS","productType":"Other Small Molecule","year":"2023","type":"Licensing Agreement","leadProduct":"Polyhexanide","moa":"Undisclosed","graph1":"Ophthalmology","graph2":"Phase III","graph3":"Avanzanite Bioscience","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Ophthalmic Solution","sponsorNew":"Avanzanite Bioscience \/ SIFI","highestDevelopmentStatusID":"10","companyTruncated":"Avanzanite Bioscience \/ SIFI"},{"orgOrder":0,"company":"Avanzanite Bioscience","sponsor":"Advicenne","pharmaFlowCategory":"D","therapeuticArea":"Nephrology","country":"NETHERLANDS","productType":"Other Small Molecule","year":"2023","type":"Agreement","leadProduct":"Potassium Citrate","moa":"||Calcium","graph1":"Nephrology","graph2":"Approved FDF","graph3":"Avanzanite Bioscience","amount2":0,"highestDevelopmentShortName":"","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Oral Granule, Prolonged Release","sponsorNew":"Avanzanite Bioscience \/ Advicenne","highestDevelopmentStatusID":"15","companyTruncated":"Avanzanite Bioscience \/ Advicenne"},{"orgOrder":0,"company":"Avanzanite Bioscience","sponsor":"Advicenne","pharmaFlowCategory":"D","therapeuticArea":"Nephrology","country":"NETHERLANDS","productType":"Other Small Molecule","year":"2023","type":"Partnership","leadProduct":"Potassium Citrate","moa":"||Calcium","graph1":"Nephrology","graph2":"Approved FDF","graph3":"Avanzanite Bioscience","amount2":0,"highestDevelopmentShortName":"","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Oral Granule, Prolonged Release","sponsorNew":"Avanzanite Bioscience \/ Advicenne","highestDevelopmentStatusID":"15","companyTruncated":"Avanzanite Bioscience \/ Advicenne"}]

    Find Clinical Drug Pipeline Developments & Deals by Avanzanite Bioscience

    Menu

    Avanzanite Bioscience

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
    filter

    Year

    filter

    DEALS // DEV.

    filter

    Country

    filter
    Sponsor
    filter

    Therapeutic Area

    filter

    Study Phase

    filter

    Deal Type

    filter

    Product Type

    filter

    Dosage Form

    filter

    Lead Product

    filter

    Target

    refresh Filters
    refresh Reset Filter
    refresh Reset Filter
    price-trend All Developments

    Therapeutic Area by Lead Product

    ForexGraph

    Study Phase by Lead Product

    ForexGraph

    Company by Lead Product

    ForexGraph

    Top Deals by Deal Size (USD bn)

    ForexGraph

    01

    Avanzanite Bioscience

    Netherlands arrow
    Interphex
    Not Confirmed

    Avanzanite Bioscience

    Netherlands arrow
    Interphex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Potassium Citrate,Potassium hydrogen carbonate

    Therapeutic Area : Nephrology

    Study Phase : Approved FDF

    Sponsor : Advicenne

    Deal Size : Undisclosed

    Deal Type : Partnership

    DEALS_DEV arrow-down

    Avanzanite Bioscience Expands Partnership with Advicenne in Additional European Countries

    Details : Under the partnership, Avanzanite gains commercialization and distribution rights into three additional European countries, for Sibnayal (potassium citrate and potassium bicarbonate), the first approved medicinal product in Europe for distal Renal Tubula...

    Product Name : Sibnayal

    Product Type : Other Small Molecule

    Upfront Cash : Undisclosed

    October 18, 2023

    Lead Product(s) : Potassium Citrate,Potassium hydrogen carbonate

    Therapeutic Area : Nephrology

    Highest Development Status : Approved FDF

    Sponsor : Advicenne

    Deal Size : Undisclosed

    Deal Type : Partnership

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    02

    Avanzanite Bioscience

    Netherlands arrow
    Interphex
    Not Confirmed

    Avanzanite Bioscience

    Netherlands arrow
    Interphex
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Polyhexanide

    Therapeutic Area : Ophthalmology

    Study Phase : Phase III

    Sponsor : SIFI

    Deal Size : Undisclosed

    Deal Type : Licensing Agreement

    DEALS_DEV arrow-down

    Sifi Announces License Agreement with Avanzanite Bioscience for Akantior®

    Details : AKANTIOR® (polihexanide) is an investigational anti-amoebic polymer that has been granted Orphan Drug Designation by both the European Medicines Agency ("EMA") and Food and Drug Administration ("FDA") for AK.

    Product Name : Akantior

    Product Type : Other Small Molecule

    Upfront Cash : Undisclosed

    October 01, 2023

    Lead Product(s) : Polyhexanide

    Therapeutic Area : Ophthalmology

    Highest Development Status : Phase III

    Sponsor : SIFI

    Deal Size : Undisclosed

    Deal Type : Licensing Agreement

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    03

    Avanzanite Bioscience

    Netherlands arrow
    Peptide-Based Therapeutics Summit
    Not Confirmed

    Avanzanite Bioscience

    Netherlands arrow
    Peptide-Based Therapeutics Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Potassium Citrate,Potassium hydrogen carbonate

    Therapeutic Area : Nephrology

    Study Phase : Approved FDF

    Sponsor : Advicenne

    Deal Size : Undisclosed

    Deal Type : Agreement

    DEALS_DEV arrow-down

    Avanzanite Bioscience Partners With Advicenne to Commercialize Sibnayal® For the Treatment of Rare Kidney Dis...

    Details : Sibnayal (potassium citrate) is a medicine used to treat patients from the age of one year with distal renal tubular acidosis (dRTA), a disease in which the kidneys do not remove acid through the urine well enough.

    Product Name : Sibnayal

    Product Type : Other Small Molecule

    Upfront Cash : Undisclosed

    February 28, 2023

    Lead Product(s) : Potassium Citrate,Potassium hydrogen carbonate

    Therapeutic Area : Nephrology

    Highest Development Status : Approved FDF

    Sponsor : Advicenne

    Deal Size : Undisclosed

    Deal Type : Agreement

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth